1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Left Ventricular Function Systolic Dysfunction: new trials by email Literature Review of Left Ventricular Function Systolic Dysfunction trials Research Report on Left Ventricular Function Systolic Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiac Safety Study in Patients With HER2 + Breast Cancer Trastuzumab, Pertuzumab, Ado Trastuzumab Emtansine - HER2 Positive Breast Cancer, Left Ventricular Function Systolic Dysfunction | Phase 2 | Completed | Medstar Health Research Institute | 31 | 2013-10-01 | 2022-05-10 |
Ado-Trastuzumab Emtansine (1) · Trastuzumab (1) · pertuzumab (1)
Medstar Health Research Institute (1)
United States (1)